Akanda Corporation has welcomed recent reports that the US administration is considering changes to federal cannabis policy, including the potential rescheduling of cannabis from Schedule I to Schedule III. The company encourages policymakers to keep reforms focused on measurable outcomes such as expanding medical research, protecting public health, supporting responsible regulation, and moving consumers away from illicit supply chains. Interim CEO Katie Field stated that modernizing cannabis policies and adopting a science-led, public-health framework could accelerate medical research, improve consumer safety, and help regulated markets move away from the risks associated with illicit supply. The company also noted that the US efforts mirror, in spirit, the approach taken by Canada with its Cannabis Act.